bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.6274
-0.0170 (-2.64%)
At close: Jul 31, 2026, 4:00 PM EDT
0.5701
-0.0573 (-9.13%)
After-hours: Jul 31, 2026, 7:34 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $2.84 million as of July 31, 2026. Its market cap has decreased by -69.05% in one year.
Market Cap
2.84M
Enterprise Value
1.13M
1-Year Change
-69.05%
Ranking
Category
Stock Price
$0.63
ChartMarket Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $2.84M, a decrease of -93.69%. That is a compound annual growth rate of -50.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.84M | -46.37% |
| Dec 31, 2025 | 5.30M | -62.63% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insight Molecular Diagnostics | 150.15M |
| Exagen | 109.44M |
| Burning Rock Biotech | 93.86M |
| Precipio | 38.70M |
| Quantum Cyber | 25.95M |
| MDxHealth | 21.47M |
| Advanced Biomed | 13.22M |
| XWELL | 8.28M |